亚太药业 (002370.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(亚太药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年年报2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 420,643,619.24301,858,122.44221,137,723.58123,584,310.47373,440,356.84234,144,248.88161,511,318.0968,322,640.18
 营业利润(元) -63,453,290.39-49,291,975.33-31,288,430.83-2,108,673.43-116,574,534.40-84,038,989.55-53,610,563.96-29,767,708.55
 利润总额(元) -11,563,677.581,793,781.2319,772,125.73-2,110,063.43-135,317,842.55-83,954,895.76-53,610,731.96-29,767,708.55
 净利润(元) -11,876,965.921,260,384.9119,766,522.01-2,618,854.09-132,720,460.20-81,384,660.92-51,930,331.02-28,871,344.89
 归属于母公司股东的净利润(元) -11,876,965.921,260,384.9119,766,522.01-2,618,854.09-132,720,460.20-81,384,660.92-51,930,331.02-28,871,344.89
盈利能力:
 销售毛利率(%) 32.0933.7736.0237.5035.7835.0636.9338.86
 销售净利率(%) -2.820.428.94-2.12-35.54-34.76-32.15-42.26
 净资产收益率(%) -2.690.335.62-0.74----
 总资产报酬率ROA(%) 1.481.992.710.53----
 投入资本回报率ROIC(%) -0.930.101.54-0.20-9.87-5.97-3.85-2.07
营运能力:
 存货周转率(次) 3.092.522.020.95----
 应收账款周转率(次) 4.993.382.461.62----
 总资产周转率(次) 0.280.210.150.08----
偿债能力:
 资产负债率(%) 59.3670.8377.5979.9880.2376.8274.0274.07
 股东权益比率(%) 40.6429.1722.4120.0219.7723.1825.9825.93
 已获利息倍数(倍) 0.651.072.010.79-2.28-1.68-1.50-1.74
 流动比率 5.906.456.135.044.525.207.844.99
 速动比率 5.325.905.584.534.064.597.264.60
发展能力:
 营业收入增长率(%) 12.6428.9236.9280.8818.507.295.82-13.51
 营业利润增长率(%) 45.5741.3541.6492.9241.527.71-44.49-24.34
 税后利润增长率(%) 91.05101.55138.0690.9341.8614.43-18.26-20.59
 净资产增长率(%) 92.8117.19-15.96-26.25-30.43-37.72-38.12-36.44
 总资产增长率(%) -6.20-6.88-2.56-4.50-5.41-12.62-17.20-19.78

前瞻产业研究院